Global Blood Therapeutics Probability of Future Stock Price Finishing Over 57.2
| GBTDelisted Stock | USD 68.49 0.00 0.00% |
Global |
Global Blood Target Price Odds to finish over 57.2
The tendency of Global Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 57.20 in 90 days |
| 68.49 | 90 days | 57.20 | about 47.22 |
Based on a normal probability distribution, the odds of Global Blood to stay above $ 57.20 in 90 days from now is about 47.22 (This Global Blood Therapeutics probability density function shows the probability of Global Stock to fall within a particular range of prices over 90 days) . Probability of Global Blood Therapeutics price to stay between $ 57.20 and its current price of $68.49 at the end of the 90-day period is about 25.45 .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.3 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Global Blood will likely underperform. Moreover Global Blood Therapeutics has an alpha of 1.1875, implying that it can generate a 1.19 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Global Blood Price Density |
| Price |
Predictive Modules for Global Blood
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Global Blood Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Global Blood's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Global Blood Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Global Blood is not an exception. The market had few large corrections towards the Global Blood's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Global Blood Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Global Blood within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 1.19 | |
β | Beta against NYSE Composite | 1.30 | |
σ | Overall volatility | 15.89 | |
Ir | Information ratio | 0.18 |
Global Blood Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Global Blood for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Global Blood Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Global Blood is not yet fully synchronised with the market data | |
| Global Blood has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 210.87 M. Reported Net Loss for the year was (309.58 M) with profit before taxes, overhead, and interest of 191.43 M. | |
| Global Blood Therapeutics has about 553.42 M in cash with (249.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.5. | |
| Over 97.0% of the company shares are owned by institutional investors |
Global Blood Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Global Stock often depends not only on the future outlook of the current and potential Global Blood's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Global Blood's indicators that are reflective of the short sentiment are summarized in the table below.
| Shares Percent Shares Out | 14.18% | |
| Short Percent Of Float | 14.58% | |
| Float Shares | 52.61M | |
| Shares Short Prior Month | 10.65M | |
| Average Daily Volume Last 10 Day | 2.06M | |
| Average Daily Volume In Three Month | 3.85M | |
| Date Short Interest | 15th of July 2022 |
Global Blood Technical Analysis
Global Blood's future price can be derived by breaking down and analyzing its technical indicators over time. Global Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Global Blood Therapeutics. In general, you should focus on analyzing Global Stock price patterns and their correlations with different microeconomic environments and drivers.
Global Blood Predictive Forecast Models
Global Blood's time-series forecasting models is one of many Global Blood's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Global Blood's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Global Blood Therapeutics
Checking the ongoing alerts about Global Blood for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Global Blood Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Global Blood is not yet fully synchronised with the market data | |
| Global Blood has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 210.87 M. Reported Net Loss for the year was (309.58 M) with profit before taxes, overhead, and interest of 191.43 M. | |
| Global Blood Therapeutics has about 553.42 M in cash with (249.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.5. | |
| Over 97.0% of the company shares are owned by institutional investors |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Global Blood Therapeutics information on this page should be used as a complementary analysis to other Global Blood's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Global Stock
If you are still planning to invest in Global Blood Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Global Blood's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |